|
Valoración de DCF Mphasis Limited (MPHASIS.NS)
IN | Technology | Information Technology Services | NSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Mphasis Limited (MPHASIS.NS) Bundle
Diseñada para la precisión, nuestra calculadora DCF (MPHASISN) le permite evaluar la valoración de Mphasis Limited utilizando datos financieros del mundo real, ofreciendo una flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 88,435.4 | 97,223.1 | 119,614.4 | 137,985.0 | 132,785.2 | 147,576.6 | 164,015.7 | 182,286.0 | 202,591.5 | 225,159.0 |
| Revenue Growth, % | 0 | 9.94 | 23.03 | 15.36 | -3.77 | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 |
| EBITDA | 18,245.5 | 19,344.0 | 22,780.6 | 25,955.6 | 26,396.9 | 29,002.6 | 32,233.3 | 35,823.8 | 39,814.4 | 44,249.5 |
| EBITDA, % | 20.63 | 19.9 | 19.04 | 18.81 | 19.88 | 19.65 | 19.65 | 19.65 | 19.65 | 19.65 |
| Depreciation | 2,316.3 | 2,417.9 | 2,907.5 | 3,252.4 | 4,105.0 | 3,832.7 | 4,259.6 | 4,734.1 | 5,261.5 | 5,847.6 |
| Depreciation, % | 2.62 | 2.49 | 2.43 | 2.36 | 3.09 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| EBIT | 15,929.1 | 16,926.2 | 19,873.0 | 22,703.2 | 22,291.9 | 25,169.9 | 27,973.6 | 31,089.7 | 34,552.9 | 38,401.9 |
| EBIT, % | 18.01 | 17.41 | 16.61 | 16.45 | 16.79 | 17.06 | 17.06 | 17.06 | 17.06 | 17.06 |
| Total Cash | 21,190.2 | 26,386.1 | 23,893.8 | 25,648.6 | 34,101.6 | 34,044.9 | 37,837.3 | 42,052.1 | 46,736.4 | 51,942.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 20,616.8 | 22,293.1 | 28,858.7 | 31,610.6 | 24,399.1 | 32,954.7 | 36,625.6 | 40,705.5 | 45,239.8 | 50,279.3 |
| Account Receivables, % | 23.31 | 22.93 | 24.13 | 22.91 | 18.37 | 22.33 | 22.33 | 22.33 | 22.33 | 22.33 |
| Inventories | 382.3 | -1,456.4 | -3,673.9 | -6,116.8 | -31.4 | -2,536.5 | -2,819.0 | -3,133.0 | -3,482.0 | -3,869.9 |
| Inventories, % | 0.43227 | -1.5 | -3.07 | -4.43 | -0.02362463 | -1.72 | -1.72 | -1.72 | -1.72 | -1.72 |
| Accounts Payable | 6,666.8 | 5,964.0 | 8,495.9 | 8,640.2 | 7,983.1 | 9,754.6 | 10,841.2 | 12,048.9 | 13,391.1 | 14,882.7 |
| Accounts Payable, % | 7.54 | 6.13 | 7.1 | 6.26 | 6.01 | 6.61 | 6.61 | 6.61 | 6.61 | 6.61 |
| Capital Expenditure | -1,261.2 | -1,261.7 | -1,200.3 | -1,131.5 | -936.9 | -1,550.4 | -1,723.1 | -1,915.0 | -2,128.3 | -2,365.4 |
| Capital Expenditure, % | -1.43 | -1.3 | -1 | -0.81998 | -0.70559 | -1.05 | -1.05 | -1.05 | -1.05 | -1.05 |
| Tax Rate, % | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 | 24.83 |
| EBITAT | 12,454.6 | 12,630.8 | 14,865.4 | 17,112.3 | 16,757.5 | 19,036.4 | 21,157.0 | 23,513.7 | 26,133.0 | 29,044.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -822.6 | 13,246.5 | 14,756.6 | 19,068.4 | 20,394.7 | 17,039.8 | 21,391.7 | 23,774.6 | 26,423.0 | 29,366.4 |
| WACC, % | 7.84 | 7.83 | 7.83 | 7.84 | 7.83 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 92,835.7 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 30,541 | |||||||||
| Terminal Value | 796,183 | |||||||||
| Present Terminal Value | 546,004 | |||||||||
| Enterprise Value | 638,840 | |||||||||
| Net Debt | 15,837 | |||||||||
| Equity Value | 623,003 | |||||||||
| Diluted Shares Outstanding, MM | 190 | |||||||||
| Equity Value Per Share | 3,278.79 |
What You Will Receive
- Authentic Mphasis Data: Preloaded financials – encompassing revenue to EBIT – derived from actual and projected figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to evaluate the effect of changes on Mphasis's fair value.
- Flexible Excel Template: Designed for rapid edits, scenario analysis, and detailed forecasting.
- Efficient and Precise: Eliminate the need to create models from the ground up while preserving accuracy and adaptability.
Key Features
- 🔍 Real-Life MPHASISNS Financials: Pre-filled historical and projected data for Mphasis Limited.
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas assess Mphasis's intrinsic value using the Discounted Cash Flow approach.
- ⚡ Instant Results: Visualize Mphasis's valuation immediately after implementing any changes.
- Scenario Analysis: Analyze and compare outcomes based on varying financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based Mphasis Limited (MPHASISNS) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells to reflect your growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically recalculate Mphasis Limited’s intrinsic value.
- Test Scenarios: Explore various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose the Mphasis Limited (MPHASISNS) Calculator?
- Time-Saving: Jump right in with a pre-built DCF model – no setup required.
- Enhanced Accuracy: Dependable financial information and formulas minimize valuation errors.
- Fully Customizable: Adjust the model to align with your unique assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs simplify the analysis of results.
- Endorsed by Professionals: Crafted for experts who prioritize both precision and ease of use.
Who Should Use This Product?
- Finance Students: Master valuation techniques and practice with actual data.
- Academics: Utilize industry-standard models in your courses or research projects.
- Investors: Evaluate your hypotheses and analyze valuation scenarios for Mphasis Limited (MPHASISNS).
- Analysts: Enhance efficiency with a ready-to-use, customizable DCF model.
- Small Business Owners: Understand how large public firms like Mphasis Limited (MPHASISNS) are valued and analyzed.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled Mphasis Limited historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), encompassing parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models demonstrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate analysis.
- Key Ratios: Contains profitability, leverage, and efficiency ratios for Mphasis Limited (MPHASISNS).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions for easy result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.